Skip to main content

Table 1 Demographic and clinical characteristics of the CAPTURE study sample overall and stratified by CVD status

From: CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

Characteristic

Overall

N = 9823

By CVD status

CVD

n = 3582

Non-CVD

n = 6241

n

Data

n

Data

n

Data

Female, n (%)

9823

4465 (45.5)

3582

1388 (38.7)

6241

3077 (49.3)

Age, years, median [IQR]

9823

64.0 [56.0–71.0]

3582

68.0 [61.0–75.0]

6241

62.0 [54.0–69.0]

Race, n (%)

9822

 

3581

 

6241

 

 White

 

6487 (66.0)

 

2558 (71.4)

 

3929 (63.0)

 Asian

 

2133 (21.7)

 

718 (20.1)

 

1415 (22.7)

 Black or African American

 

158 (1.6)

 

66 (1.8)

 

92 (1.5)

 Other

 

1044 (10.6)

 

239 (6.7)

 

805 (12.9)

Diabetes duration, years, median [IQR]

9811

10.7 [5.6–17.9]

3577

13.0 [7.2–20.0]

6234

9.8 [4.8–15.9]

HbA1c, %, median [IQR]

9104

7.30 [6.60–8.40]

3289

7.40 [6.60–8.50]

5815

7.30 [6.50–8.30]

HbA1c, mmol/mol, median [IQR]

9104

56 [49–68]

3289

57 [49–69]

5815

56 [48–67]

FPG, mmol/L, median [IQR]

8204

7.60 [6.30–9.38]

2924

7.60 [6.21–9.43]

5280

7.60 [6.33–9.32]

Body weight, kg, median [IQR]

9742

79.3 [68.7–92.0]

3550

79.8 [69.0–92.0]

6192

79.0 [68.3–92.0]

BMI, kg/m2, median [IQR]

9611

29.0 [25.8–33.1]

3514

28.9 [25.7–33.1]

6097

29.1 [25.8–33.1]

Systolic blood pressure, mmHg, median [IQR]

9618

130.0 [120.0–140.0]

3531

130.0 [120.0–142.0]

6087

130.0 [120.0–140.0]

Diastolic blood pressure, mmHg, median [IQR]

9616

78.0 [70.0–82.0]

3529

76.0 [70.0–81.0]

6087

80.0 [70.0–83.0]

Total cholesterol, mmol/L, median [IQR]

8272

4.34 [3.68–5.14]

3001

4.05 [3.39–4.82]

5271

4.51 [3.83–5.26]

LDL cholesterol, mmol/L, median [IQR]

8090

2.39 [1.81–3.08]

2924

2.12 [1.62–2.77]

5166

2.54 [1.98–3.19]

HDL cholesterol, mmol/L, median [IQR]

7965

1.15 [0.98–1.40]

2907

1.11 [0.93–1.32]

5058

1.18 [0.99–1.42]

Triglyceride, mmol/L, median [IQR]

8466

1.60 [1.13–2.27]

3082

1.61 [1.14–2.30]

5384

1.59 [1.13–2.25]

eGFR, mL/min/1.73 m2, n (%)

7923

 

2888

 

5035

 

 > 89

 

2746 (34.7)

 

707 (24.5)

 

2039 (40.5)

 > 59–89

 

3512 (44.3)

 

1293 (44.8)

 

2219 (44.1)

 > 29–59

 

1450 (18.3)

 

757 (26.2)

 

693 (13.8)

 ≤ 29

 

215 (2.7)

 

131 (4.5)

 

84 (1.7)

Albuminuriaa, n (%)

6482

 

2433

 

4049

 

 Normal–mildly increased

 

4338 (66.9)

 

1396 (57.4)

 

2942 (72.7)

 Microalbuminuria

 

1607 (24.8)

 

774 (31.8)

 

833 (20.6)

 Macroalbuminuria

 

537 (8.3)

 

263 (10.8)

 

274 (6.8)

Medical history of hypertension, yes, n (%)

9643

6756 (70.1)

3522

2918 (82.9)

6121

3838 (62.7)

Familial hypercholesterolemia, yes, n (%)

6634

676 (10.2)

2342

246 (10.5)

4292

430 (10.0)

Retinopathy, n (%)

9818

 

3578

 

6240

 

 Yes

 

1455 (14.8)

 

725 (20.3)

 

730 (11.7)

 Yes (referred by participant)

 

399 (4.1)

 

144 (4.0)

 

255 (4.1)

 No

 

7964 (81.1)

 

2709 (75.7)

 

5255 (84.2)

Nephropathy, n (%)

9818

 

3579

 

6239

 

 Yes

 

1771 (18.0)

 

917 (25.6)

 

854 (13.7)

 Yes (referred by participant)

 

337 (3.4)

 

128 (3.6)

 

209 (3.3)

 No

 

7710 (78.5)

 

2534 (70.8)

 

5176 (83.0)

Neuropathy, n (%)

9817

 

3577

 

6240

 

 Yes

 

1774 (18.1)

 

867 (24.2)

 

907 (14.5)

 Yes (referred by participant)

 

459 (4.7)

 

168 (4.7)

 

291 (4.7)

 No

 

7584 (77.3)

 

2542 (71.1)

 

5042 (80.8)

Smoking status, n (%)

9725

 

3547

 

6178

 

 Current

 

1322 (13.6)

 

465 (13.1)

 

857 (13.9)

 Previous

 

2613 (26.9)

 

1268 (35.7)

 

1345 (21.8)

 Never

 

5790 (59.5)

 

1814 (51.1)

 

3976 (64.4)

Duration of smokingb, years, median [IQR]

3733

28.0 [15.0–39.0]

1646

30.0 [20.0–40.0]

2087

25.0 [15.0–35.0]

Physical activityc, days per week, n (%)

7492

 

2763

 

4729

 

 0–1

 

3599 (48.0)

 

1515 (54.8)

 

2084 (44.1)

 2–3

 

1613 (21.5)

 

497 (18.0)

 

1116 (23.6)

 4–5

 

883 (11.8)

 

264 (9.6)

 

619 (13.1)

 6–7

 

1397 (18.6)

 

487 (17.6)

 

910 (19.2)

  1. To convert the values for glucose to mg/dL, divide by 0.0555. To convert the values for cholesterol to mg/dL, divide by 0.0259. To convert the values for triglycerides to mg/dL, divide by 0.0113. Data that were missing from the medical record but verbally confirmed by a participant were coded as ‘referred by participant’. Data were not weighted
  2. aDefined as: normal–mildly increased, urinary excretion < 30 mg/24 h or UACR < 30 mg/g; microalbuminuria, urinary excretion 30–299 mg/24 h or UACR 30–299 mg/g; macroalbuminuria, urinary excretion ≥ 300 mg/24 h or UACR ≥ 300 mg/g
  3. bOnly applies to participants categorized as current or previous smokers
  4. cDays with ≥ 30 min of moderate activity
  5. BMI body mass index, CVD cardiovascular disease, eGFR estimated glomerular filtration rate, FPG fasting plasma glucose, HbA1c glycated hemoglobin, HDL high-density lipoprotein, IQR interquartile range, LDL low-density lipoprotein, UACR urinary albumin to creatinine ratio
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840